Sutera, Philip
Van Der Eecken, Kim
Kishan, Amar U. http://orcid.org/0000-0002-7437-6591
Hamid, Anis
Grist, Emily
Attard, Gerhardt http://orcid.org/0000-0002-4811-7983
Lotan, Tamara
Mendes, Adrianna A.
Paller, Channing J. http://orcid.org/0000-0003-3658-1858
Carducci, Michael A.
Ross, Ashley http://orcid.org/0000-0001-7044-9688
Wang, Hao http://orcid.org/0000-0001-6489-6940
Pienta, Ken http://orcid.org/0000-0002-4138-2186
Feng, Felix Y. http://orcid.org/0000-0002-0963-7687
Antonarakis, Emmanuel S.
Ost, Piet http://orcid.org/0000-0002-2203-4848
Song, Daniel Y.
Greco, Stephen
Deville, Curtiland http://orcid.org/0000-0003-4846-6486
DeWeese, Theodore
Tran, Phuoc T.
Deek, Matthew P. http://orcid.org/0000-0002-5949-5058
Article History
Received: 1 September 2021
Revised: 22 November 2021
Accepted: 29 November 2021
First Online: 11 January 2022
Competing interests
: Consultant for Pfizer, Exelexis. ESA: Patent holder/licenser for Qiagen; Consultant for Amgen, Astellas, AstraZeneca, Bayer, Clovis, Dendreon, Eli Lilly and Co. ESSA, GlaxoSmithKline, Jannsen, Medivation, Merck, and Sanofi; Research grant recipient from AstraZeneca, Bristol Myers-Squibb, Celgene, Clovis, Dendreon, Genentech, Janssen, Johnson & Johnson, Merck, Novartis, Sanofi, Tokai. PO: Consultant for Bayer, Janssen, Curium; Research grant recipient from Varian, Bayer. AG: Relationship with Janssen and Astellas; Royalties from ICR. AR: Speaker’s Bureau for Blue Earth and Janssen; Stock Options from Decipher Biosciences; Consultant to Astellas. PT: Research funding from Astellas Pharm, Bayer Healthcare and RefleXion Medial Inc; Consultant for RefleXion, Grants from RefleXion; Personal fees from Noxopharm, Janssen-Taris Biomedical, Myovant and AstraZeneca; Holds a patent 9114158- Compounds and Methods of Use in Ablative Radiotherapy licensed to Natsar Pharm.